DarioHealth Corp reports results for the quarter ended in December - Earnings Summary

DarioHealth

09/03/2023 14:31

* DarioHealth Corp  DRIO.OQ  reported a quarterly adjusted
loss
of 51 cents​​ per share for the quarter ended in December. The
mean expectation of five analysts for the quarter was for a loss
of 65 cents per share.
    * Revenue rose 13% to $6.81 million from a year ago;
analysts
expected $6.29 million. 
    * DarioHealth Corp's reported EPS for the quarter was a loss
of 51
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * DarioHealth Corp shares had risen by 15.2% this quarter.
    * The company reported a quarterly loss of $12.88 million.
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 02:30 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.65          -0.51          Beat
 Sep. 30 2022      -0.76          -0.64          Beat
 Jun. 30 2022      -0.71          -0.74          Missed
 Mar. 31 2022      -0.96          -0.74          Beat